← Leaderboards
Daniel Lodge
South Texas Veterans Health Care System
$4,188,028
Attributed
$4,859,944
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $552.1K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,859,944 · 3
VA$0 · 2
By mechanism
R01$4,461,319 · 2
R21$398,625 · 1
I01$0 · 2
Top collaborators
- Stephanie Marie Perez3 shared
- Xin-Yun Lu2 shared
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineBehaviorDopamine SystemBehavioralRodent ModelRattusSymptomsPharmaceutical PreparationsDopaminergic NeuronFunctional DisorderReportingRegulationNeuronsSchizophreniaReceptorAlzheimer&AposLocomotionAffectTransmission ProcessResponseNeurophysiologyCognitiveNew Therapeutic TargetVentral Tegmental Area
Grant awards (24)
Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis$310,840
R01 · FY2025 · AG
The orexin system as a target for PTSD and comorbid psychosis$0
I01 · FY2025 · VA · contact PI
Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis$317,184
R01 · FY2024 · AG
Mechanisms contributing to co-morbid psychosis in Alzheimer's disease$0
I01 · FY2024 · VA · contact PI
Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis$317,184
R01 · FY2023 · AG
Mechanisms contributing to co-morbid psychosis in Alzheimer's disease$0
I01 · FY2023 · VA · contact PI
The Orexin System as a Target for PTSD and Comorbid Psychosis$0
I01 · FY2023 · VA · contact PI
The Orexin System as a Target for PTSD and Comorbid Psychosis$0
I01 · FY2022 · VA · contact PI
Mechanisms contributing to co-morbid psychosis in Alzheimer's disease$0
I01 · FY2022 · VA · contact PI
The Orexin System as a Target for PTSD and Comorbid Psychosis$0
I01 · FY2021 · VA · contact PI
Mechanisms contributing to co-morbid psychosis in Alzheimer's disease$0
I01 · FY2021 · VA · contact PI
The Orexin System as a Target for PTSD and Comorbid Psychosis$0
I01 · FY2020 · VA · contact PI
Regulation of ventral hippocampal system function$357,533
R01 · FY2019 · MH · contact PI
Regulation of ventral hippocampal system function$357,533
R01 · FY2018 · MH · contact PI
Regulation of ventral hippocampal system function$357,533
R01 · FY2017 · MH · contact PI
Regulation of ventral hippocampal system function$333,220
R01 · FY2016 · MH · contact PI
Regulation of ventral hippocampal system function$488,088
R01 · FY2015 · MH · contact PI
Regulation of ventral hippocampal system function$330,784
R01 · FY2014 · MH · contact PI
Regulation of ventral hippocampal system function$317,552
R01 · FY2013 · MH · contact PI
Adiponectin regulation of the mesolimbic dopamine system$177,295
R21 · FY2013 · MH
Regulation of ventral hippocampal system function$330,784
R01 · FY2012 · MH · contact PI
Adiponectin regulation of the mesolimbic dopamine system$221,330
R21 · FY2012 · MH
Regulation of ventral hippocampal system function$330,784
R01 · FY2011 · MH · contact PI
Regulation of ventral hippocampal system function$312,300
R01 · FY2010 · MH · contact PI